1 - 2 / 2 1 |
1. Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy Sanja Nabergoj, Irena Mlinarič-Raščan, Žiga Jakopin, 2019, pregledni znanstveni članek Ključne besede: adjuvants, cancer immunotherapy, immunotherapeutics, NOD1 agonists, NOD1 antagonists, NOD2 agonists, NOD2 antagonists |
2. Discovery of desmuramylpeptide NOD2 agonists with single-digit nanomolar potency Samo Guzelj, Špela Bizjak, Žiga Jakopin, 2022, izvirni znanstveni članek Ključne besede: NOD2, desmuramylpeptide, immunostimulant, adamantane, PBMC cytotoxicity, K562, agonists, cells, peptides and proteins, reaction products, toxicological synergy |